We are live on ! Find out more
PAHC icon

Phibro Animal Health

149 hedge funds and large institutions have $265M invested in Phibro Animal Health in 2022 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 54 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

1% more funds holding

Funds holding: 148149 (+1)

2% less repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 54

3.63% less ownership

Funds ownership: 101.62%97.99% (-3.6%)

33% less capital invested

Capital invested by funds: $395M → $265M (-$130M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $199K

Holders
149
Holders Change
+1
Holders Change %
+0.68%
% of All Funds
2.57%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
24
Increased
53
Reduced
54
Closed
21
Calls
Puts
$199K
Net Calls
-$199K
Net Calls Change
-$199K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$49.5M -$3.31M -191,914 -5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$30.7M +$659K +38,193 +2%
Pzena Investment Management
3
Pzena Investment Management
New York
$25.5M -$255K -14,741 -0.8%
State Street
4
State Street
Massachusetts
$11.8M +$405K +23,483 +3%
HA
5
Heartland Advisors
Wisconsin
$10.2M -$636K -36,818 -5%
Millennium Management
6
Millennium Management
New York
$8.72M +$10.8M +623,858 +1,924%
Renaissance Technologies
7
Renaissance Technologies
New York
$7.2M -$1.03M -59,400 -10%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$6.93M -$200K -11,578 -2%
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$6.6M +$5.42M +313,819 +171%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$5.58M -$353K -20,444 -5%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$5.07M +$210K +12,167 +3%
SGCIA
12
Smith Graham & Co Investment Advisors
Texas
$4.86M +$746K +43,191 +13%
Goldman Sachs
13
Goldman Sachs
New York
$4.72M -$4.68M -271,081 -43%
N
14
Nuveen
North Carolina
$4.43M -$97.5K -5,649 -2%
Victory Capital Management
15
Victory Capital Management
Texas
$4.23M -$2.23M -129,019 -29%
Ameriprise
16
Ameriprise
Minnesota
$4.23M +$3.96M +229,279 +257%
DRZID
17
DePrince Race & Zollo Inc (DRZ)
Florida
$4.16M -$2.51M -145,249 -32%
Morgan Stanley
18
Morgan Stanley
New York
$3.78M +$755K +43,740 +18%
Charles Schwab
19
Charles Schwab
California
$3.45M +$35K +2,026 +0.8%
HIM
20
Hillsdale Investment Management
Ontario, Canada
$3.27M
PAIM
21
Punch & Associates Investment Management
Minnesota
$2.95M -$3.09M -178,992 -45%
Northern Trust
22
Northern Trust
Illinois
$2.94M -$106K -6,155 -3%
Wells Fargo
23
Wells Fargo
California
$2.67M -$355K -20,582 -9%
BIP
24
Brandes Investment Partners
California
$2.64M +$1.66M +96,317 +94%
Invesco
25
Invesco
Georgia
$2.42M +$135K +7,841 +5%

PAHC Hedge Fund Activity: Q3 2022 in Review

149 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q3 2022, worth a combined $265M — down 33% from $395M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PAHC positions and 21 closed out — a net gain of 3 holders — while 53 added to existing stakes and 54 trimmed.

The largest buyer was Millennium Management, adding an estimated $10.8M. The largest seller was Fiduciary Management Inc, exiting entirely with an estimated $17M sold.

  • 149 institutional investors held Phibro Animal Health (PAHC) as of Q3 2022, up from 148 in Q2 2022.
  • Funds reported $265M of Phibro Animal Health stock for Q3 2022, down 33% quarter-over-quarter.
  • 24 funds opened new Phibro Animal Health positions in Q3 2022 and 21 closed out, a net change of +3 holders.
  • The largest Phibro Animal Health buyer in Q3 2022 was Millennium Management, an estimated $10.8M added.
  • The largest Phibro Animal Health seller in Q3 2022 was Fiduciary Management Inc, an estimated $17M sold.

Based on aggregated 13F filings for Q3 2022.